Results 251 to 260 of about 2,232,804 (291)
Some of the next articles are maybe not open access.
European Journal of Surgical Oncology (EJSO), 2008
As clinical awareness increases, carcinoid is becoming increasingly identified, often at an earlier stage in the course of the disease. However, many patients remain undiagnosed until well into the late stages of the illness, at the time when their carcinoid syndrome becomes apparent. This review examines contemporary methods of detecting and assessing
J, Bendelow +3 more
openaire +2 more sources
As clinical awareness increases, carcinoid is becoming increasingly identified, often at an earlier stage in the course of the disease. However, many patients remain undiagnosed until well into the late stages of the illness, at the time when their carcinoid syndrome becomes apparent. This review examines contemporary methods of detecting and assessing
J, Bendelow +3 more
openaire +2 more sources
JAMA: The Journal of the American Medical Association, 1988
SELECTED CASE A WOMAN was well until the age of 54 years when she developed asthma, which was treated with albuterol and steroids. Two years later she noticed intermittent diarrhea and flushing. When first seen, five years after the onset of asthma, she gave a history of flushing of the upper part of her body, a 4.5-kg weight loss, and diarrhea.
openaire +3 more sources
SELECTED CASE A WOMAN was well until the age of 54 years when she developed asthma, which was treated with albuterol and steroids. Two years later she noticed intermittent diarrhea and flushing. When first seen, five years after the onset of asthma, she gave a history of flushing of the upper part of her body, a 4.5-kg weight loss, and diarrhea.
openaire +3 more sources
Endocrine Practice, 2016
OBJECTIVE To evaluate the efficacy and safety of lanreotide depot/autogel 120 mg for the control of carcinoid syndrome (CS) symptoms in patients with neuroendocrine tumors (NETs).
A. Vinik +4 more
semanticscholar +1 more source
OBJECTIVE To evaluate the efficacy and safety of lanreotide depot/autogel 120 mg for the control of carcinoid syndrome (CS) symptoms in patients with neuroendocrine tumors (NETs).
A. Vinik +4 more
semanticscholar +1 more source
Carcinoid tumor and carcinoid syndrome
Current Opinion in Anaesthesiology, 2003Carcinoid tumors secrete many different types of substances (e.g. serotonin, bradykinin) that may produce potentially fatal intraoperative reactions such as hypotension and bronchoconstriction. The most effective treatment for the deleterious cardiovascular and pulmonary effects of serotonin and bradykinin is octreotide, a somatostatin analogue ...
openaire +3 more sources
Histamine in carcinoid syndrome
Agents and Actions, 1988The exact etiology of carcinoid flushing remains unknown, but the symptoms are probably mediated through release of one or several humoral substances. Flushing seen in fore-gut carcinoids (gastric carcinoids) has been ascribed to excessive histamine release, whereas flushing seen in mid-gut carcinoids (ileal carcinoids) tentatively has been ascribed to
S. Boesby, J. Gustafsen, W. K. Man
openaire +3 more sources
Archives of Surgery, 1959
The malignant carcinoid syndrome is manifested by (1) paroxysmal flushing, (2) chronic diarrhea, (3) respiratory distress, and (4) valvular heart disease. These abnormalities result from a marked increase in the amount of circulating serotonin. The abnormal clinical findings in this syndrome result principally from the action of serotonin on the ...
Wilson, Harwell, Storer, Edward H.
openaire +4 more sources
The malignant carcinoid syndrome is manifested by (1) paroxysmal flushing, (2) chronic diarrhea, (3) respiratory distress, and (4) valvular heart disease. These abnormalities result from a marked increase in the amount of circulating serotonin. The abnormal clinical findings in this syndrome result principally from the action of serotonin on the ...
Wilson, Harwell, Storer, Edward H.
openaire +4 more sources
Scleroderma and the carcinoid syndrome
Clinical and Experimental Dermatology, 1994The follow up of a case of the carcinoid syndrome complicated by scleroderma is reported, in which progress of the disease may have been halted by treatment with a combination of cyproheptadine, parachlorophenylalanine and prednisolone. Impairment of tryptophan and 5-hydroxytryptamine (serotonin) metabolism appears central to the development of skin ...
R.J. Pye, N.P. Burrows, R.C. Ratnavel
openaire +3 more sources
, 2015
Excessive serotonin secretion is the hallmark of carcinoid syndrome. It leads to diarrhea, cramping, abdominal pain, wheezing and flushing. It is also associated with serious cardiac valve disease and lower life expectancy.
P. Lapuerta +4 more
semanticscholar +1 more source
Excessive serotonin secretion is the hallmark of carcinoid syndrome. It leads to diarrhea, cramping, abdominal pain, wheezing and flushing. It is also associated with serious cardiac valve disease and lower life expectancy.
P. Lapuerta +4 more
semanticscholar +1 more source